Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Detection marker and kit for B lymphoma and leukemia and application of detection marker and kit

A lymphoma and leukemia technology, applied in the field of medicine, can solve the problems of sensitivity to chemotherapy drugs, difficult treatment of patients, and little effect

Active Publication Date: 2017-05-24
FUDAN UNIV
View PDF3 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although more than 50% of patients can be cured by this treatment plan, at least 1 / 3 of patients are refractory to treatment or relapse
Such patients will be treated with autologous hematopoietic stem cell transplantation to sensitize them to chemotherapy drugs of the standard regimen, but with little success

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Detection marker and kit for B lymphoma and leukemia and application of detection marker and kit
  • Detection marker and kit for B lymphoma and leukemia and application of detection marker and kit
  • Detection marker and kit for B lymphoma and leukemia and application of detection marker and kit

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0053] Example 1. Immunohistochemical analysis of the expression of P4HA2 protein in diffuse large B lymphoma.

[0054] Test materials and their preparation: 205 cases of diffuse large B lymphoma and 20 cases of reactive hyperplastic lymph node tissue samples were collected and fixed in buffered formalin for 24 hours. Rinse with running water for 1 hour, place the sample in 30% and 50% ethanol for 30 minutes each, and finally store in 70% ethanol at 4°C. The fixed samples were first dehydrated with gradient ethanol, transparent in xylene, and then embedded in paraffin at about 52°C, and the slices with a thickness of 4-10 μm and a diameter of 0.1 mm were pasted on Polyurethane in a dot arrangement. Tissue chips were prepared on clean glass slides treated with amino acid. Bake the slices overnight at 34°C and store in a sealed container at 4°C.

[0055] Operation method: Take the prepared tissue chip, dewax it with xylene, rehydrate with gradient ethanol, then add 0.3% hydrog...

Embodiment 2

[0057] Example 2, the expression intensity of P4HA2 protein is related to the classification and prognosis of diffuse large B lymphoma

[0058]According to the results of Example 1, the correlation between the expression of P4HA2 protein in diffuse large B lymphoma and clinicopathological parameters was further analyzed. The results are shown in Table 1. There was no correlation between the expression of P4HA2 and age and gender, but there was a significant correlation with the classification and prognosis of diffuse large B lymphoma. P4HA2 expression was higher in patients with more aggressive non-GCB diffuse large B lymphoma. The IPI is scored by five pathological indicators related to prognosis, and the higher the score, the worse the prognosis. The higher the expression of P4HA2, the higher the IPI score, and the poorer the prognosis of diffuse large B lymphoma.

[0059] Table 1. Correlation analysis between P4HA2 expression intensity and clinicopathological indicators ...

Embodiment 3

[0061] Example 3, Analysis of the expression intensity of P4HA2 protein and the median survival time of patients with diffuse large B lymphoma

[0062] According to the results of Example 1, we also analyzed the correlation between P4HA2 and the median survival time of patients with diffuse large B lymphoma. It was found that the stronger the expression of P4HA2, the shorter the median survival time of patients with non-GCB diffuse large B lymphoma. This shows that P4HA2 is indeed closely related to the occurrence and development of diffuse large B lymphoma, and can be used as a marker for the diagnosis or treatment of diffuse large B lymphoma.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of medicines, and in particular discloses a detection marker and kit for B lymphoma and leukemia and application of the detection marker and the kit. The invention provides a P4HA2 gene or protein and application of Carabin protein in preparation of a diagnosis kit or treating B lymphoma and leukemia. Study shows that the P4HA2 gene and protein are barely expressed or slightly expressed in normal people or reactive lymph nodes, and are remarkably highly expressed in diffuse large B cell lymphoma; Carabin protein is slightly expressed in the diffuse large B cell lymphoma. In addition, the expression of the P4HA2 gene in an acute myeloid leukemia blood sample is remarkably higher than that in normal people; the diffuse large B cell lymphoma of which expression of the P4HA2 gene is knocked down is slowly proliferated, and the tumorigenic ability of a nude mouse is remarkably degraded. Therefore, the P4HA2 gene can be used as a diagnosis marker and a treatment target of the hematopoiesis and lymphoma, and the Carabin protein can be also used as a diagnosis marker of such diseases. The invention further provides a corresponding detection method and kit.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a detection marker for B lymphoma or leukemia, a kit and its application in the preparation of antitumor drugs. Background technique [0002] Prolyl-4-hydroxylase (P4H) catalyzes proline residues in mammalian cells, yielding (2S,4R)-4-hydroxyproline. Prolyl-4-hydroxylase has a wide range of substrates, the most important of which is to catalyze the newly synthesized collagen precursor, and its folding to form a correct three-dimensional conformation is critical and necessary. The substrate for mammalian prolyl-4-hydroxylase is an alpha 2 beta 2 A tetramer whose α-subunit has a substrate-binding domain and an enzymatic active site. The α subunit has three subtypes, and the subunit type 1 (prolyl 4-hydroxylase, alpha polypeptide Ⅰ, referred to as "P4HA1") is the most widely expressed enzyme. Prolyl 4-hydroxylase type II α subunit (prolyl 4-hydroxylase, alpha polype...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N15/53C12N15/12C12N9/02C07K14/47C12Q1/68G01N33/68G01N33/574G01N33/573
CPCC07K14/47C12N9/0071C12Q1/6886C12Q2600/156C12Q2600/158C12Y114/11002G01N33/573G01N33/57426G01N33/68G01N2333/90245
Inventor 党永军蒋维李增霞周晓燕刘凯玉崔照盟谭仁可
Owner FUDAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com